International Journal For Multidisciplinary Research

E-ISSN: 2582-2160   •   Impact Factor: 9.24

A Widely Indexed Open Access Peer Reviewed Multidisciplinary Bi-monthly Scholarly International Journal

Call for Paper Volume 6 Issue 6 November-December 2024 Submit your research before last 3 days of December to publish your research paper in the issue of November-December.
Submit Research Paper Join as a Reviewer

Plagiarism is checked by the leading plagiarism checker TurnItIn

Call for Paper

Volume 6 Issue 6
November-December 2024

Submit your research paper

Indexing Partners
Academia Advanced Sciences Index Bielefeld Academic Search Engine CiteSeer DRJI Google Scholar Independent Search Engine & Directory Network ISI (International Scientific Indexing) Issuu Mendeley Research Networks
RefSeek ResearcherId - Thomson Reuters ResearchGate Scirus Scribd Semantic Scholar UTeM - Universiti Teknikal Malaysia Melaka Wiki for Call for Papers WorldCat Zenodo

Virtual Screening for Identification of Pyridines and Pyrimidines as Potent CDK9 Inhibitors

Author(s) Keerthana G, M Vijaya Bhargavi
Country India
Abstract Cyclin-dependent kinase 9 (CDK9) has emerged as a promising therapeutic target for various cancers and viral infections due to its crucial role in cell cycle regulation and transcriptional control. In this study, we present a comprehensive virtual screening approach aimed at identifying novel pyridine and pyrimidine derivatives as potent CDK9 inhibitors. Utilizing computational tools and molecular docking simulations, we screened a large chemical library to prioritize compounds with favorable binding affinities and pharmacokinetic properties. Subsequent in silico ADMET (absorption, distribution, metabolism, excretion, and toxicity) analysis was employed to assess the drug-likeness and safety profile of the identified candidates. The top-ranking compounds were further evaluated through molecular dynamics simulations to elucidate their dynamic behavior and stability within the CDK9 binding pocket. Our findings reveal several promising pyridine and pyrimidine derivatives with potential CDK9 inhibitory activity, warranting further experimental validation and optimization for therapeutic development against cancer and other CDK9-associated diseases. This integrative computational approach demonstrates its efficacy in accelerating drug discovery efforts and offers valuable insights into structure-activity relationships for the design of novel CDK9 inhibitors.
Keywords CDK9 inhibitors, anti cancer drugs, virtual screening, pyridines, pyrimidines.
Field Chemistry > Pharmacy
Published In Volume 6, Issue 4, July-August 2024
Published On 2024-08-17
Cite This Virtual Screening for Identification of Pyridines and Pyrimidines as Potent CDK9 Inhibitors - Keerthana G, M Vijaya Bhargavi - IJFMR Volume 6, Issue 4, July-August 2024. DOI 10.36948/ijfmr.2024.v06i04.26223
DOI https://doi.org/10.36948/ijfmr.2024.v06i04.26223
Short DOI https://doi.org/gt7m49
View / Download PDF File

Share this



E-ISSN 2582-2160
CrossRef

CrossRef DOI is assigned to each research paper published in our journal.

IJFMR DOI prefix is
10.36948/ijfmr

Downloads
Research Paper Format Copyright Permission Form and Undertaking Form Cover Page Vol 6 Isu 6Cover Page Vol 6 Isu 5Cover Page Vol 6 Isu 4

All research papers published on this website are licensed under Creative Commons Attribution-ShareAlike 4.0 International License, and all rights belong to their respective authors/researchers.

CC-BY-SA Open Access

About IJFMR
Fees & Payment
Current Issue
Publication Archive 		Submit Research Paper
Track Submission Status
Publication Guidelines
Publication Ethics
Peer Review & Plagiarism 		Join as a Reviewer
Editors & Reviewers
Reviewer Referral Program
Get Reviewer Membership Certi. 		Website/Journal Policies
Usage Policy
Content Policies
Privacy Policy
Contact Us +91-9898-5948-55 editor@ijfmr.com